These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 487818

  • 1. First year clinical experience with six levonorgestrel rods as subdermal contraception.
    Faundes A, Brache de Mejias V, Leon P, Robertson D, Alvarez F.
    Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
    [Abstract] [Full Text] [Related]

  • 2. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S, Stanczyk F, Mishell DR, Lumkin M, Gentzschein E.
    Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA, Brandeis V, Cruz RI, Kelly S, Sweeney M.
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Subdermal contraceptive implants.
    Peralta O, Diaz S, Croxatto H.
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A new delivery system for contraceptive steroids.
    Segal S.
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 12. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, Biswas A, Viegas O, el din Abdalla K, Anant MP, Pavez M, Stern J.
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [Abstract] [Full Text] [Related]

  • 13. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
    Robertson DN, Sivin I, Nash HA, Braun J, Dinh J.
    Contraception; 1983 May; 27(5):483-95. PubMed ID: 6411428
    [Abstract] [Full Text] [Related]

  • 14. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I, el Mahgoub S, McCarthy T, Mishell DR, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A.
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [Abstract] [Full Text] [Related]

  • 15. Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.
    Holma P, Robertson DN.
    Contraception; 1985 Aug; 32(2):163-71. PubMed ID: 3935372
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE, Odlind V, Johansson ED, Nordström ML.
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three-year experience with NORPLANT subdermal contraception.
    Sivin I, Sanchez FA, Diaz S, Holma P, Coutinho E, McDonald O, Robertson DN, Stern J.
    Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.